Teva- Pharmaceutical Industries Ltd
Teva- Pharmaceutical Industries Ltd (TEVA) Implied Volatility Current
TEVA implied volatility is 34%. IV Rank is 17%, placing current premiums in the bottom of their 52-week range.
Read more
Tracking TEVA implied volatility helps you identify when options premiums on Teva- Pharmaceutical Industries Ltd are historically cheap or expensive, and where the best trades are hiding. Teva- Pharmaceutical Industries Ltd implied volatility reflects the market's expectation of future price movement: when TEVA IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Teva- Pharmaceutical Industries Ltd's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For TEVA, tracking metrics like TEVA IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on TEVA signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas.
Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where TEVA implied volatility sits today versus where it has been. Our scanner ranks Teva- Pharmaceutical Industries Ltd implied volatility against its historical range, surfaces extremes in TEVA IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Teva- Pharmaceutical Industries Ltd IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is compressed vs the past year - options are relatively cheap, favoring buyers.
As of September 17, 2026
Trade options with IV on your side
Track TEVA IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→